Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements and Hierarchy (Tables)

v3.22.2.2
Fair Value Measurements and Hierarchy (Tables)
12 Months Ended
Dec. 31, 2021
Class of Warrant or Right [Line Items]  
Schedule of carrying amounts of financial instruments

​

​

​

​

​

​

​

​

​

​

​

Successor

​

​

Predecessor

​

​

December 31, 

​

​

December 31, 

​

    

2021

  

  

2020

Financial Assets:

 

​

  

​

 

​

  

Cash

​

$

140,477,586

​

​

$

36,261,104

Restricted Cash

​

$

356,286

​

​

$

3,641,843

Clinics Fees and Insurance Receivables, Net

​

$

1,090,104

​

​

$

675,954

Other Receivables

​

$

726,903

​

​

$

146,117

Financial Liabilities:

​

 

  

​

​

 

  

Accounts Payable and Accrued Expenses

​

$

17,730,683

​

​

$

11,793,125

Liability for Warrants

​

$

11,382,826

​

​

$

6,316,605

Summary of changes in company's Level 3 fair value measurements

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Successor

 

  

Predecessor

​

   

December 3, 2021

  

  

​

​

    

​

​

​

through

​

​

​

​

Year

​

​

December 31,

​

​

January 1, 2021

​

Ended

​

​

2021

​

​

through

​

December

​

​

(Private

​

​

December 2, 2021

​

31, 2020

​

​

Placement

​

​

(Class D

​

(Class D

​

​

Warrants)

​

​

Warrants)

​

Warrants)

Beginning Balance

​

$

793,650

​

​

$

6,316,605

​

$

N/A

Issuance of Class D Warrants

​

​

—

​

​

​

—

​

​

6,316,605

Mark-to-Market Adjustment for Stock Warrants

​

 

(291,374)

​

​

 

7,664,869

​

 

—

Ending Balance

​

$

502,276

​

​

$

13,981,474

​

$

6,316,605

Class D Warrants  
Class of Warrant or Right [Line Items]  
Summary of Level 3 inputs into option pricing model

​

​

​

​

​

​

Volatility

    

​

65.0

%

Risk-Free Interest rate

 

​

0.10

%

Exercise Price

​

$

4.68

​

Expected Term

​

 

1.1

Years

​

Private Placement Warrants  
Class of Warrant or Right [Line Items]  
Summary of Level 3 inputs into option pricing model

​

​

​

​

​

​

Volatility

    

​

60.0

%  

Risk-Free Interest rate

 

​

1.26

%  

Exercise Price

​

$

11.50

 

Expected Term

​

 

4.9

Years